Publications (18) MARTA MOYA MONTES publications

2024

  1. Bacterial lipopolysaccharide forms aggregates with apolipoproteins in male and female rat brains after ethanol binges

    Journal of Lipid Research, Vol. 65, Núm. 3

2023

  1. Reelin Plasma Levels Identify Cognitive Decline in Alcohol Use Disorder Patients During Early Abstinence: The Influence of APOE4 Expression

    The international journal of neuropsychopharmacology, Vol. 26, Núm. 8, pp. 545-556

  2. Treatment with Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical Practice

    Crohn's and Colitis 360, Vol. 5, Núm. 1

2022

  1. Disinhibition-Like Behavior Correlates with Frontal Cortex Damage in an Animal Model of Chronic Alcohol Consumption and Thiamine Deficiency

    Biomedicines, Vol. 10, Núm. 2

  2. Oleoylethanolamide attenuates the stress-mediated potentiation of rewarding properties of cocaine associated with an increased TLR4 proinflammatory response

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 124

  3. Upregulation of TLR4/MyD88 pathway in alcohol-induced Wernicke’s encephalopathy: Findings in preclinical models and in a postmortem human case

    Frontiers in Pharmacology, Vol. 13

2021

  1. Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 108

  2. Effects of Alcohol Binge Drinking and Oleoylethanolamide Pretreatment in the Gut Microbiota

    Frontiers in Cellular and Infection Microbiology, Vol. 11

2014

  1. A simple transcriptomic signature able to predict drug-induced hepatic steatosis

    Archives of Toxicology, Vol. 88, Núm. 4, pp. 967-982

2013

  1. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; And repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1831, Núm. 4, pp. 803-818

2012

  1. Altered glucose-stimulated insulin secretion in a mouse line with activated polyamine catabolism

    Transgenic Research, Vol. 21, Núm. 4, pp. 843-853

  2. Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver

    PLoS ONE, Vol. 7, Núm. 1

  3. Vascular endothelial growth factor-mediated islet hypervascularization and inflammation contribute to progressive reduction of β-cell mass

    Diabetes, Vol. 61, Núm. 11, pp. 2851-2861

2010

  1. Enhanced steatosis by nuclear receptor ligands: A study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile

    Chemico-Biological Interactions, Vol. 184, Núm. 3, pp. 376-387

  2. Interaction between Hhex and SOX13 modulates Wnt/TCF activity

    Journal of Biological Chemistry, Vol. 285, Núm. 8, pp. 5726-5737

2009

  1. Transcriptional regulation of cytochrome P450 genes by the nuclear receptor hepatocyte nuclear factor 4-alpha

    Current Drug Metabolism, Vol. 10, Núm. 5, pp. 508-519

2006

  1. Expression of IGF-I in pancreatic islets prevents lymphocytic infiltration and protects mice from type 1 diabetes

    Diabetes, Vol. 55, Núm. 12, pp. 3246-3255

  2. In vivo gene transfer to healthy and diabetic canine pancreas

    Molecular Therapy, Vol. 13, Núm. 4, pp. 747-755